APA (7th ed.) Citation

Saito, N., Hatanaka, T., Nakano, S., Hazama, Y., Yoshida, S., Hachisu, Y., . . . Uraoka, T. (2022). A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab. Clinical Case Reports, 10(7), 1. https://doi.org/10.1002/ccr3.6129

Chicago Style (17th ed.) Citation

Saito, Naoto, et al. "A Case of Unresectable Combined Hepatocellular and Cholangiocarcinoma Treated with Atezolizumab Plus Bevacizumab." Clinical Case Reports 10, no. 7 (2022): 1. https://doi.org/10.1002/ccr3.6129.

MLA (9th ed.) Citation

Saito, Naoto, et al. "A Case of Unresectable Combined Hepatocellular and Cholangiocarcinoma Treated with Atezolizumab Plus Bevacizumab." Clinical Case Reports, vol. 10, no. 7, 2022, p. 1, https://doi.org/10.1002/ccr3.6129.